Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients

Michael J. Dawson; Philip Doble; Alison Beavis; Ling-Xi L. Li; Robyne Soper; Richard A Scolyer; Roger F. Uren; John F. Thompson

doi:10.1039/b300527e

Abstract

1 min read

A sensitive, accurate and specific method for the analysis of antimony by ICP-MS is presented as a marker of the sentinel lymph node in melanoma patients.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma–Mass Spectrometry

Alison Beavis, Michael J. Dawson, Philip Doble, Richard A Scolyer, Roger Bourne, Ling-Xi L. Li, Rajmohan Murali, Jonathan R. Stretch, Cynthia L. Lean, Roger F. Uren, John F. Thompson

Article2003

Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence

Ling-Xi L. Li, Richard A Scolyer, Vivian S. K. Ka, J. Gregory McKinnon, Helen M. Shaw, Stanley W. McCarthy, John F. Thompson

Article2008

Sentinel Lymph Node Biopsy for Melanoma: Aspects of Pathologic Assessment

Rajmohan Murali, John F. Thompson, Richard A Scolyer

Article2004

Micromorphometric Features of Positive Sentinel Lymph Nodes Predict Involvement of Nonsentinel Nodes in Patients With Melanoma

Richard A Scolyer, Ling-Xi L. Li, Stanley W. McCarthy, Stanley W. McCarthy, Helen M. Shaw, Jonathan R. Stretch, Raghwa Sharma, John F. Thompson

Article2004

Micromorphometric Features of Positive Sentinel Lymph Nodes Predict Involvement of Nonsentinel Nodes in Patients With Melanoma

Richard A Scolyer, Ling-Xi L. Li, Stanley W. McCarthy, Helen M. Shaw, Jonathan R. Stretch, Raghwa Sharma, John F. Thompson